Neuropsychology in Alzheimer's disease and other dementia research

Current Opinion in Psychiatry
Gauri Nayak Savla, Barton W Palmer

Abstract

This review describes a variety of neuropsychological dementia studies published between January 2004 and June 2005. In selecting articles for description in the present paper, our goal was not a comprehensive review of what is an enormous and growing literature, but rather to select and describe individual interesting studies from a sufficient range of dementia-related topics to permit illustration of some of the important questions for which a neuropsychological perspective aids in the understanding of dementias. Findings in the studies reviewed include a variety of different topics. Some of the themes include the following: (a) Alzheimer's disease is the most common cause of dementia, but a large body of research documents that there are important cognitive differences among various types of dementia, (b) the emerging research is also important in demonstrating the need for more sensitive clinical screening measures, (c) cognitive data are strongly predictive of functional decline, and (d) subtle declines in verbal learning appear to precede clinical Alzheimer's disease. Neuropsychological data are key to progress in understanding and developing more effective treatments for Alzheimer's disease and other dementia. For instan...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Nov 1, 1992·Journal of Clinical Psychology·T Swirsky-SacchettiC F Gonzalez
Mar 1, 1988·Neurobiology of Aging·W W BeattyE L Granholm
Nov 1, 1987·Acta Psychiatrica Scandinavica·A F JormA S Henderson
Nov 1, 1987·Urology·M S KaplanM C Benson
Jan 1, 1993·The Journal of Neuropsychiatry and Clinical Neurosciences·J C Rothlind, J Brandt
Dec 16, 1996·Annals of the New York Academy of Sciences·G W SmallA D Roses
Mar 31, 1998·Archives of Neurology·P R SolomonW W Pendlebury
May 5, 1999·Neurology·S A SmallR Mayeux
Sep 9, 1999·Psychiatric Services : a Journal of the American Psychiatric Association·J L Cummings, D V Jeste
Dec 22, 1999·Drugs & Aging·L FratiglioniH Agüero-Torres
May 20, 2000·Annals of the New York Academy of Sciences·H Agüero-Torres, B Winblad
Aug 10, 2000·Journal of Neurology·P Garrard, J R Hodges
Feb 22, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·J S SnowdenD Neary
Dec 26, 2001·Archives of Neurology·R C PetersenB Winblad
Feb 27, 2003·Acta Neurologica Scandinavica. Supplementum·Brent J SmallLars Bäckman
Sep 11, 2003·Annals of Internal Medicine·David A Snowdon, UNKNOWN Nun Study
Dec 11, 2003·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Joel H KramerBruce L Miller
Jan 31, 2004·Journal of the International Neuropsychological Society : JINS·David A LoewensteinRanjan Duara
Apr 6, 2004·Clinics in Geriatric Medicine·David S Geldmacher
Apr 6, 2004·International Journal of Geriatric Psychiatry·J GuarchR Blesa
Apr 20, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·E F J MeulenF R Verhey
Apr 21, 2004·Archives of Neurology·Margaret M SwanbergJeffrey L Cummings
May 19, 2004·Journal of the International Neuropsychological Society : JINS·James A LevyTrey Sunderland
Aug 4, 2004·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Giuseppe SartoriIrene Daum
Aug 26, 2004·Journal of the International Neuropsychological Society : JINS·Joanne M HamiltonLeon J Thal
Aug 26, 2004·Journal of the International Neuropsychological Society : JINS·Julie A TestaGlenn E Smith
Oct 30, 2004·Journal of Clinical and Experimental Neuropsychology·Larry PriceKathleen Y Haaland
Dec 9, 2004·Psychology and Aging·Debra A FleischmanDavid A Bennett
Dec 15, 2004·The Clinical Neuropsychologist·Bruce R ReedHelena C Chui
Dec 15, 2004·The Clinical Neuropsychologist·Patricia A BoyleRonald A Cohen
Feb 3, 2005·Journal of the International Neuropsychological Society : JINS·Tara T LineweaverJody Corey-Bloom
Feb 3, 2005·Journal of the International Neuropsychological Society : JINS·Martijn MeeterPhilip Scheltens
Apr 9, 2005·Journal of the American Geriatrics Society·Ziad S NasreddineHoward Chertkow

❮ Previous
Next ❯

Citations

May 26, 2012·Experimental Gerontology·Nicholas BakerGro V Amdam
Aug 7, 2008·Phytotherapy Research : PTR·Andrew PipingasJoseph Nastasi
Jun 6, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Kai Hsin LiaoCalvin Yu-Chian Chen
May 3, 2007·Journal of Integrative Neuroscience·Evian GordonLeanne M Williams
Oct 23, 2015·Molecular Neurobiology·Nan-Nan YuLan Tan
Sep 11, 2012·Journal of Clinical Biochemistry and Nutrition·Mikiyuki KatagiriTakuji Shirasawa

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.